SAGE
Sage Therapeutics, Inc.
20.35
USD
This page is just a preview of the data found in TrendSpider’s full version
Sage Therapeutics, Inc. stock is up 10% since 30 days ago. The next earnings date is Feb 15, 2024. The company has had below-average volume in the last 30 days. Its seasonality going into this month shows a chance of a green month, as 60% of the previous 9 December’s closed higher than November. In the last 10 Unusual Options Trades, there were 3 PUTs, 7 CALLs.
| Date & Time | Expiration Date | Strike Price | Trade Type | Size | Open Interest |
|---|---|---|---|---|---|
| 10 Oct 19:25 | 19 Jan, 2024 | 20.00 | 467 | ||
| 11 Oct 15:48 | 17 Nov, 2023 | 22.50 | 672 | ||
| 12 Oct 17:42 | 17 Nov, 2023 | 22.50 | 1314 | ||
| 17 Oct 17:33 | 17 May, 2024 | 22.50 | 0 | ||
| 20 Oct 15:40 | 17 Nov, 2023 | 17.50 | 616 | ||
| 20 Oct 19:59 | 17 Nov, 2023 | 20.00 | 698 | ||
| 23 Oct 15:25 | 19 Jan, 2024 | 25.00 | 70 | ||
| 25 Oct 14:17 | 17 Nov, 2023 | 17.50 | 1842 | ||
| 08 Nov 20:54 | 16 Feb, 2024 | 20.00 | 246 | ||
| 13 Nov 15:05 | 19 Jan, 2024 | 15.00 | 26 |
Sage Therapeutics, Inc. develops and commercializes medicines to treat central nervous system disorders. Its lead product candidate is ZULRESSO, an intravenous formulation of brexanolone for the treatment of postpartum depression (PPD) In addition, its product pipeline comprises SAGE-718, an oxysterol-based positive allosteric modulator of the NMDA receptor.
